American Society of Cataract and Refractive Surgery to Include Multiple Glaukos Technologies Presentations
4/11/18: Clinical trial results and personal experience data will be discussed to be discussed.
International Study Shows Two Glaukos iStent® Trabecular Micro-Bypass Stents and One Topical Medication Deliver Sustained IOP Reduction
86% of Eyes Had IOP ≤ 18 mm Hg at Three Years Postoperative, According to Results Published...
Early-Stage Sensor Technology Expected to Complement the Glaukos Pipeline of Micro-Scale Glaucoma Devices and Drug-Delivery Systems April 12,...